chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was diagnosed with Shingles on 11-JUN-2021 after presenting with nerve pain and blistering rash on back and front left shoulder and left and back of the neck. 22-MAY-2021: Itchiness and red blotchiness appeared on left front chest and shoulder.  Lasted for several hours and then resolved.  No doctor contacted. 31-MAY-2021: 2nd round of itchiness on front left shoulder and left side neck.  Lasted several hours and resolved itself. No doctor contacted. 07-JUN-2021: Left front and back shoulder was sore to the touch, hot like a sunburn, and tight muscle pain thru shoulder and left neck. 08-JUN-2021: Symptoms worsened throughout day and then nerve pain was present during the night thru left shoulder and left side and back of the neck. 09-JUN-2021: Had a teladoc doctor visit about severe shoulder/neck pain.  Pain medicine was prescribed and instructed to see PCP if symptoms did not resolve. Small bumps appeared on left back shoulder as if bitten by a bug.  10-JUN-2021:  Shoulder/neck pain still present and took motrin every 4 hours for pain.  Used heat pad for pain.  More bumps appeared on front left chest and back left shoulder. 11-JUN-2021: Rash worsened with blisters forming and spreading further on left chest and shoulder and up left and back of the neck.  Pain was still present.  Teladoc was called again and shown pictures of rash.  Diagnosed with Shingles and prescribed Valtrex. 12-17-JUN-2021: Pain and rash still present with ice pick headaches occurring every few seconds many times a day. 18-JUN-2021 to present: Rash and pain began to recover but still present to date.
I started getting chills around 8:00pm the same day I got my 2nd dose of Moderna?s COVID-19 vaccination. In the night I had a fever (105 F), sore muscles, headache, nausea, and fatigue. My fever continued throughout the day and is now (99 F) at 5:15pm the next day after receiving the vaccine. Fatigue, headache, and sore muscles have also continued.
Mother brought child on 12/1/05 with these symptoms: swelling and redness of RUE, no pain, fever, no improvement of swelling with ice. No prior immunization reactions. NRA, no respiratory difficulty. Doctor examined child and prescribed Benadryl (12.5/5cc) 2.5cc PO every 4-6 hours until reaction resolved and Amoxicillin (250mg/5cc) 5cc PO TID for 10 days. Instructed to RTC/ER PRN respiratory difficulty, worsening S/S or other concerns.
Urinary Tract Infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Urinary Tract Infection) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 14-Mar-2021, the patient experienced URINARY TRACT INFECTION (Urinary Tract Infection). The patient was treated with CIPROFLOXACIN on 15-Mar-2021 at a dose of 500 milligram twice a day and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 25-Mar-2021, URINARY TRACT INFECTION (Urinary Tract Infection) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient took Gatorade,Pedialyte and Water along with other concomitant medications.   This case was linked to US-MODERNATX, INC.-MOD-2021-068605 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068605:MOD-2021-068605 -2nd dose of vaccine
11/19/04 acc to mother, fever started late evening 101-102. Mild soreness, redness at injection site. No vomiting. 11/21/04 acc to mom. Fever 105 - apparent seizure - hands drew up as clams, eyes rolled, to ER - life flighted to another hospital where they gave amoxycillin and sent home for no apparent problems after shots on 12/29/04 - DTap & Hib
Pfizer 3/15/21, 4/5/21, 1/18/22. Positive on 1/26/22
Information has been received from a health professional concerning an 18 year old white female with a septra allergy who on 07/05/2001 was vaccinated with hep b vaccine recombinant. There was no illness at the time of vaccination. On 07/08/2001 the pt experienced a sore throat, runny nose and generally did not feel well. It was reported that she also experienced a low grade fever, uper abdominal pain, cramps, vomiting and flu-like symptoms. A strep culture was done which was negative. Unspecified medical attention was sought. The pt has recovered.
A nurse reported that a 4 year old male, inadvertently, received an injection of Prevnar on 6/12/00, after receiving an injection on 5/29/00. Shortly after the 2nd dose, he developed a low-grade fever, temperament changes and an injection site reaction. As of 6/27/00, the fever and injection site reaction had resolved, but the temperament changes remained.
Chills, low grade fever, body aches, headache " brain fog"; Chills, low grade fever, body aches, headache " brain fog"; Chills, low grade fever, body aches, headache " brain fog"; Chills, low grade fever, body aches, headache " brain fog"; Chills, low grade fever, body aches, headache " brain fog"; This is a spontaneous report from a contactable other healthcare professional. A 44-year-old female patient received (not pregnant) her first dose of bnt162b2 (BNT162B2 also reported as Covid 19brand Pfizer BioNTech, lot EJ1685), intramuscular in the left arm 22Dec2020 10:00 at SINGLE DOSE for Covid-19 immunisation. She received the vaccine in a hospital. Medical history included covid prior vaccination: Yes. No other vaccine in four weeks. The patient's concomitant medications were not reported. The patient experienced chills, low grade fever, body aches, headache " brain fog" on 23Dec2020 01:00. No treatment was given. The outcome of events was recovered.  No follow-up attempts are possible. No further information is expected.
Initial unsolicited report received from a Physician on 16 Feb 2015. A 11-year-old female patient, whose medical history and concomitant medications were none, had received a first dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (Adacel) (batch number U4965AA, expiry date 12-FEB-2017, Intramuscular route in the left deltoid) on 14 Feb 2015, received a dose of HEPATITIS A VACCINE (HEP A) (batch number unknown Intramuscular route on left deltoid) on 14 Feb 2015, received a dose of INFLUENZA VIRUS VACCINE POLYVALENT (Fluvirin) (batch number unknown Intramuscular route on left deltoid) on 14 Feb 2015, received a dose of HUMAN PAPILLOMA VIRUS VACCINE (HPV) (batch number unknown Intramuscular route on right deltoid on 14 Feb 2015 and received a dose of MENINGOCOCCAL A-C-Y-W135 (D CRM197 CONJ) VACCINE (Menveo) (batch number unknown Intramuscular route on right deltoid on 14 Feb 2015. Any other vaccinations before 4 weeks prior to Adacel vaccine were not reported. On 15 Feb 2015 the patient developed site reaction of redness, swelling, warmth on left deltoid and site reaction of redness, swelling on right deltoid. Laboratory investigations were none and she was prescribed with Bactrim and Ice packs. The outcome of the events was unknown. Patient required emergency room visit. Documents held by sender: none. Follow up information was received from a physician on 16 March 2015: It was reported that the patient was not visited the emergency room and event was occurred after 2 days. At the time of this report, outcome of the event was resolved on an unspecified date.
Significant fatigue (could not get out of bed all day), Significant joint pain, chills, fever, headache
Fever, shivers, nausea, vomiting, diarrhea, fatigue, headache
Information has been received from a state immunization offician concerning a patient who was vaccinated with two doses of varicella virus vaccine live. The patient subsequently tested seronegative for antibodies. Additional information is not expected.
"my face got swollen for days"; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non pregnant female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 03Apr2021 at 11:00 (at the age of 34-year-old) (Lot Number: ER8134) as dose 1, single for covid-19 immunisation. Medical history included arrhythmia. Concomitant medications included iron, magnesium, prenatal vitamins and probiotics medications in two weeks. The patient previously experienced known allergies for penicillin, cephalopods, shellfish, pollens and Fruit allergy (Allergy to apple). The patient reported event described as my face got swollen for days from 03Apr2021 at 11:30. It was reported that within 30 minutes (including 15minutes of wait after vaccination) my face got swollen for days. Allergic to many things. However my husband who IS allergic to nothing got his face swollen too after vaccination. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination. Patient did not receive treatment post onset of event. Outcome of the event was recovered with sequelae.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021407191 same drug/AE, different patient
Has not gotten the second dose yet; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not gotten the second dose yet) in a 31-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not gotten the second dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not gotten the second dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Non significant Follow up appended
Did you/the patient previously receive a COVID-19 Vaccine?: Yes; COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Mar2021 as dose 1, single (Lot number: EP7534), in left arm, on 08Apr2021 as dose 2, single (Lot number: EW015B), in left arm and on 28Jan2022 as dose 3 (booster), single (Lot number: 33130BA) at the age of 50 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "hysterectomy" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "cholecystectomy" (unspecified if ongoing); "appendectomy" (unspecified if ongoing); "tubal ligation" (unspecified if ongoing). Concomitant medication(s) included: DULOXETINE; PREVACID; RESTASIS; METOPROLOL; VITAMIN D NOS; CLARITINE; VITAMIN B COMPLEX. Past drug history included: Taviste-d, reaction(s): "known allergies Taviste-D", notes: known allergies Taviste-D. The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", described as "Did you/the patient previously receive a COVID-19 Vaccine?: Yes"; COVID-19 (medically significant), outcome "unknown". Therapeutic measures were taken as a result of vaccination failure, covid-19.   Clinical course included Known allergies of Taviste-D. Treatment for COVID-19 included paxlovid.  No follow-up attempts possible. No further information expected.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect drug to the reported events Vaccination failure , COVID-19  cannot be completely excluded based on temporal association.
Several days after vaccination after, experienced slight headaches and  on 9/17/21 began slight heart palpitations and weakness. Went home to rest. Symptoms continued and were followed by dizziness. Heart palpitations persisted. Since onset of symptoms, palpitations come and go.
extensive menstruation, 3 plus months; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 16-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious) with onset 01Jan2022, outcome "recovered" (30Mar2022), described as "extensive menstruation, 3 plus months". Therapeutic measures were taken as a result of heavy menstrual bleeding.  Additional Information: Adverse event: Sixteen year old female with extensive menstruation, 3 plus months. Family physician advised possible cause Pfizer Covid Vaccine, however, did not confirm. After three months, female was seen by a gynecologist, where in different treatment was offered, and successful, but also indicated possible cause may be related to the Pfizer Covid vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Reporter stated that because their facility was not been able to download the digital data logger, they have been put on hold by the State at the movement and were not administering the Moderna COVID-19 vaccine to the patients until an assessment was made by the State. The reporter also stated that there had been no power outages that would have impacted the Moderna vaccine. The reporter stated that however, because their facility was unable to download the digital data logger, they treated this issue as a temperature excursion. It was also reported that the data logger which was unable to download was for the months of Dec-2021, Jan-2022 and Feb-2022. Reporter stated that no adverse reactions were reported by any patients.  No treatment medications were reported.
scalp pain; This is a spontaneous report from a non-contactable consumer (patient) via the Pfizer Sponsored Program Corporate (Pfizer) Social Media Platforms.   A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient experienced scalp pain on an unspecified date with outcome of unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Woke up with nausea and a stomachache. Later also developed chills and body aches. I also had some shortness of breath, but this has been ongoing for the past 2 months of my pregnancy so probably wasn't related. Left work early at 4pm due to the body aches, nausea, and chills (was supposed to work until 7:30 pm). At 4:30, I developed a fever up to 100.9F. I took acetaminophen at home. I called on call physician whom I heard back from at 6:30pm. She advised me to go to the ED to evaluate the fever. At ED, where I was for almost 5 hours, I had vital signs checked, a CBC drawn, a flu swab sent, and a urinalysis sent. All were within normal limits according to staff. I was discharged home from the ED, and the physician felt it could have been a viral illness or perhaps a side effect from the TDAP vaccine the day prior. On 10/24/13, I developed increased swelling at the injection site also.
Within a week, thumping heart often during the day.  Reduced after taking NSAIDs.  Difficulty sleeping due to fluttering/thumping heart.
12/1/22 All of a sudden, I just started putting on weight. I went to the doctor and said I needed to lose weight.  He did not explain why I suddenly started gaining.
Patient noticed blurred vision starting around 5 and 1/2 hours after his vaccine.  This blurred vision lasted about 3 days.  5 days after the vaccine he noticed that his vision had improved.  It was improved even from baseline.  He could not see things clearly without his glasses.
Sore arm at the injection site; slight headache; This is a spontaneous report from a contactable consumer (Pfizer colleague) reported for herself. A 33-year-old female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration at left arm on 28Jan2021 09:30 at SINGLE DOSE for covid-19 immunization.  Medical history was none. There were no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient had no other medications received within 2 weeks of vaccination. The patient experienced sore arm at the injection site, and a slight headache both on 29Jan2021. The patient did not receive treatment for the adverse event. Since the vaccination, the patient had not been tested for COVID-19. The outcome was recovering. The seriousness from reporter was non-serious.
pt recv vax 09AUG94 & 11UAG94 mom noticed swelling of both hands of son; swelling was localized around the knuckles & the joints in the finger of both hands & was accompanied by some itching;
sore throat; rash on side of arm; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), RASH (rash on side of arm), HEADACHE (Headache) and PYREXIA (Fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), RASH (rash on side of arm), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with IBUPROFEN for Headache, Sore throat, Fever and Rash, at an unspecified dose and frequency. On 15-Apr-2021, OROPHARYNGEAL PAIN (sore throat), RASH (rash on side of arm), HEADACHE (Headache) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-117894 (Patient Link).
24 hrs after receiving the Varicella vaccine pt's arm swelled, became very warm and redness that mom described as being approx 10-15 cm in diameter around the site of the injection.  Pt had decreased range of motion in the arm and pain that required motrin for relief.  Pt is much improved on the fourth day.
pt recv vax & had episode of grayish color, inc temp 102 & unresponsive-episode lasted 15min & back to nl;self w/in 1hr;seen by MD p/hr but fine when seen;2nd dose of vax not given;
Lymph nodes under injection arm became very tender and caused severe pain in the underarm area.  This reaction happened 7 days after the vaccine and last for a little under 3 days.
About 3-4 hours after receiving my second dose of vaccine on 1/30/21, I began to experience side effects including headache, myalgias, and fatigue (which I had also experienced with the first dose of vaccine). I had no nausea or vomiting until around 8-9 pm on 1/31/21. At that time I began to have severe nausea and had 1-2 episodes of emesis before falling asleep. I woke up around 3 am and had another episode of emesis. This continued every 15-30 minutes. I was unable to keep any fluids down as a result. After a couple of hours of this I became lightheaded and began to experience abdominal pain after repeated retching. Sometime between 6 am and 7 am I called 911 and was connected to nursing line. I was advised to go to the emergency department. After vomiting another 2 times I called 911 again and asked for an ambulance to be sent. I vomited again in the ambulance before arrival. Once in the ED I was examined, found to be tachycardic, and started on 1L of IV fluids. I was informed lab tests were being drawn, including pregnancy test, urinalysis, CBC, CMP, and toxicology screen. I was given one dose of Zofran IV. Nausea began to subside, and I was able drink fluids without nausea or vomiting. I was informed that lab tests were unremarkable. Another 1L of IV fluids had been started, but I was disconnected after maintaining PO intake and eventually discharged around 12 pm.
warm, trouble breathing, nausea, chest pressure, arm burning, increased blood pressure  Next day f/u - stick neck, shoulder pain + heat, left cheek swollen been taking tylenol and benadryl saw PCP - received rx for prednisone
Sitting on sofa, calm and all of a sudden around 3 pm and even though I was sitting down, I became dizzy, nauseous, and started to have EXTREME heart palpitations.  I had mild side effects from the vaccine throughout the week, but this heart issue occurred 4 days after Pfizer shot 1.  It lasted for several minutes.   I took 2 aspirins, tylenol, and went to bed.  I woke up the next day!  However, ever since this occurred, I have had a tightness in my chest, and extreme fatigue.  I have reported my vaccine issue 2x to my doctor but doubt she made any effort to report it on VAERS which by law its her duty to do so.  As such, am reporting it as I would like to have a written record that this episode occurred after my shot 1 of Pfizer.